Developing CMC Strategies for Radiopharmaceuticals from Academia to Commercial

Time: 11:30 am
day: Conference Day Two

Details:

  • Investigator INDs to Commercial INDs: Considerations for comparibility and bridging
  • Developing a qTPP
  • Enabling Type C Meetings for Phase 3

Speakers: